Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of fecal mesalazine concentrations for therapeutic drug monitoring in ulcerative colitis
NL-OMON48827Active, not recruiting
- Sponsor
- Maag, darm, leverziekten
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of Salcrozine in autoimmune colitis (2 arms), sponsored by Maag, darm, leverziekten. Started May 2018; status: active, not recruiting.
02
Drugs
Salcrozine
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on NL-OMON48827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48827.